Laboratory Analytical Instruments Companies
FilingsAtlas covers 21 publicly traded US companies in the Laboratory Analytical Instruments industry (SEC SIC code 3826). Together they are worth about $222.63B in market value; the largest are Agilent Technologies (A), Waters (WAT), Illumina (ILMN). By revenue, the biggest is Agilent Technologies with $6.95B in fiscal 2025. 7 of the 21 companies with a reported fiscal year were profitable.
| # | Company | Ticker | Market Cap | Revenue (latest FY) | Net Income | Revenue YoY | P/E |
|---|---|---|---|---|---|---|---|
| 1 | Agilent Technologies, Inc. | A | $48.56B | $6.95B FY2025 | $1.30B | +6.7% | 37.5 |
| 2 | Waters Corp | WAT | $42.15B | $3.17B FY2025 | $642.6M | +7.0% | 39.9 |
| 3 | Illumina, Inc. | ILMN | $41.49B | $4.34B FY2025 | $850.0M | -0.7% | 49.8 |
| 4 | Mettler Toledo International Inc/ | MTD | $32.23B | $4.03B FY2025 | $869.2M | +4.0% | 38.0 |
| 5 | Revvity, Inc. | RVTY | $17.31B | $2.86B FY2025 | $241.2M | +3.7% | 74.9 |
| 6 | Avantor, Inc. | AVTR | $10.53B | $6.55B FY2025 | -$530.2M | -3.4% | — |
| 7 | Bio-rad Laboratories, Inc. | BIO | $9.75B | $2.58B FY2025 | $759.9M | +0.7% | 13.1 |
| 8 | 10x Genomics, Inc. | TXG | $9.33B | $642.8M FY2025 | -$43.5M | +5.2% | — |
| 9 | Bruker Corp | BRKR | $8.56B | $3.44B FY2025 | -$8.6M | +2.1% | — |
| 10 | Cytek Biosciences, Inc. | CTKB | $692.6M | $201.5M FY2025 | -$66.5M | +0.5% | — |
| 11 | Pacific Biosciences of California, Inc. | PACB | $636.8M | $160.0M FY2025 | -$546.4M | +3.9% | — |
| 12 | 908 Devices Inc. | MASS | $456.1M | $56.2M FY2025 | $19.5M | -5.8% | 22.4 |
| 13 | EyePoint Pharmaceuticals, Inc. | EYPT | $265.7M | $31.4M FY2025 | -$232.0M | -27.5% | — |
| 14 | Nautilus Biotechnology, Inc. | NAUT | $260.6M | $0 FY2025 | -$59.0M | — | — |
| 15 | Quanterix Corp | QTRX | $148.6M | $138.9M FY2025 | -$107.2M | +1.1% | — |
| 16 | Seer, Inc. | SEER | $116.4M | $16.6M FY2025 | -$73.6M | +17.0% | — |
| 17 | Rapid Micro Biosystems, Inc. | RPID | $42.3M | $33.6M FY2025 | -$47.1M | +19.7% | — |
| 18 | Precipio, Inc. | PRPO | $40.4M | $24.0M FY2025 | -$363,000 | +29.8% | — |
| 19 | Harvard Bioscience Inc | HBIO | $37.4M | $86.5M FY2025 | -$56.7M | -8.1% | — |
| 20 | Bionano Genomics, Inc. | BNGO | $15.7M | $28.5M FY2025 | -$26.4M | -7.4% | — |
| 21 | ASTROTECH Corp | ASTC | $10.3M | $913,000 FY2026 | -$14.4M | -8.7% | — |
Market cap and P/E use the latest closing price; revenue and net income are from each company's most recent annual report (10-K) filed with the SEC. Click a company for its full financial statements.